Enzolytics Inc (ENZC)

[Timing101]

HERE YOU GO !
==
ENZC DD here folks, links, facts, Input . There was a very special reason the disclosure on 3/16/2022. It was all about extracted information (between those dates mentioned and from Audited data provided and approved , plus AUDITED via PCAOB Auditor Malone Bailey LLC)
. One has to READ and understand something in Disclosures when it is stated and do some DD on what it means. Again as an “example” this is what CEO Charles Crotopia and the ENZC Mgt Team could say to assist one to understand these facts (all can be researched, Factual off Disclosures, Legal reference and statements ). Doing this as you know I supply links of DD always and also go back and read , just to make sure all the data points line up to what I ‘believe’ I know, but is based on facts , not IMO’s of someone that just makes general statements. Go to the Company disclosures.
Here you go, if one does not get it , then you should probably just let go of your shares to the folks that are right there to buy them within seconds. This is a great area to load up on , if you can by the way.
https://www.otcmarkets.com/otcapi/company/financial-report/323613/content
=====================
What Charles could say to assist. (but he has said it the Legal Lingo way) .
**
I and the team know frustration by some shareholders is out there, but I do have to start with what is stated below is, that I have been a Patent, Intellectual Property and Corporate accredited attorney for over 40 years. During that time I have represented or have been involved in hundreds of cases involving many companies and have seen the issues caused by not doing the correct Legal Protection of such assets as Patents , Proprietary Information , Trade Secrets and from outside sources that attempt to invade such assets.
I (we) have attempted to say this had to be done in a variety of ways in PR Releases, Disclosures and addressing such risks as we knew them (plus have arisen) in the past 18 Months that I have been CEO.
I am (or ENZC Mgt) not anyone’s Financial Advisor, Investment Broker, Market Maker advisor or do we control any such activities in the Stock Market, that is totally up to the individuals that participate in the Daily Stock Transactions.
I will report however since I have been the CEO and with the ENZC Team we have accomplished in just 18 months a tremendous amount of Legal Success protecting the ENZC future , plus the Stock price has gone up over 500 % during that time. Please feel free to research any item below, the links are there for one to read and check on , that is up to each individual to do their OWN Due Diligence. The ENZC TEAM and I are here for one reason, that is to have a “Successful Company that contributes to the betterment of Health and Human Care”.
-
1. If one recalls, I became CEO on 10/22/20 which is documented. However prior to that time as an attorney , I had reviewed the risks, pro’s, con’s with Harry Zhabilov information that was provided, plus from my other Bioclonetics Partners. In that time it was determined that enough Value and Return , made it logical to proceed. Many Legal steps and preparation were taking place place prior to the CEO announcement as it was obvious there would be roadblocks and Hurdles ahead. One can see preparation work prior to the CEO announcement here with Merger news and other items prior to the 10/22/20 date.
See here PR and News Releases prior to that date
https://www.otcmarkets.com/stock/DEVM/profile
-
2. On 1/11/21, we issued a PR release about Malone Bailey a global PCAOB official auditor had been engaged. If one was to read the release , it is very clear that the years 2019 and 2020 were the target years to be audited by Malone Bailey LLC, an SEC approved Auditing firm that handles OTC , Nasdaq and NY Stock Exchange clients in the US . In turn Malone Bailer LLC , was also Identified as the new Auditing firm that would be releasing disclosures from that point on for the rest of 2021 and also continuing from there.
https://www.otcmarkets.com/stock/ENZC/news/Enzolytics-Inc-Engages-PCAOB-Auditor-for-December-31-2020-Year-End-Audit?id=285813
-
3. The Year 2020 was a very, very complicated year as one can see by the amount of disclosures , Bioclonetics Merger, Re Alignment after the Re Incorporation in Delaware SOS , Dealing with the Toxic Lending, Creating Subsidiaries and the hundreds of administrative Legal and Process items that came with it . One should not underestimate the amount of Auditing , Research it took from Malone Bailey LLC , to research the above items and EVERY thing prior from the OLD ENZC.
It is all in the disclosures , however one should concentrate on the recent filings of the Annual AMENDED 2020 report and the Annual and Financial Annual 2021 report as they are the most current and approved by the PCAOB SEC APPROVED Auditing firm Malone Bailey LLC . here you go
https://www.otcmarkets.com/stock/ENZC/disclosure
-
4. In closing , a very specific and actually a disclosure that is not normally done by any Company was filed and disclosed.
https://www.otcmarkets.com/otcapi/company/financial-report/323613/content
--
Please note the highlighted areas which you can review in person .
a. The following information has been extracted from OTC Quarterly and Annual Reports. This information is being offered to help the public analyze the equity issues of conversions, dilution, and other topics about which the public may have interest. ( Disclosure to the PUBLIC SHAREHOLDERS and anyone else in the PUBLIC)
*
b. This information lists each original common stock issuance of Enzolytics, Inc. (“ENZC” or the “Company”), and its predecessors, from April 6, 2012 through October 15, 2020. There have been no original issuance of ENZC shares since October 15, 2020. ENZC is a Delaware Corporation that filed a reorganization merger under 251g of the Delaware Corporate Statute on November 16, 2020 ( Note the 251g, is for Delaware SOS only and it was a confirmed merger done to protect all interest via the ReIncorporation .This is why ENZC went to the Delaware SOS, one can research the Legal definition of a 251g Merger)
*
c. All outstanding debt of the Company flowed to its subsidiary, now known as Robustomed, Inc. This means there are no outstanding convertible debt pieces of ENZC common equity, and that has been the case since November 30, 2020. This has been disclosed in all filings made on OTC (both annual and quarterly) since that date. (This was done to protect the NEW ENZC in Legal Ways from the past history of the OLD ENZC , but adding another LEGAL Buffer and by making a President position there (Steve Sharabura) )
*
d. All outstanding debt of the Company flowed to its subsidiary, now known as Robustomed, Inc. This means there are no outstanding convertible debt pieces of ENZC common equity, and that has been the case since November 30, 2020. This has been disclosed in all filings made on OTC (both annual and quarterly) since that date(all disclosed , Legal , had to be done to separate that Convertible Toxic Debt and issues it could cause for New ENZC)
*
e. On the attached schedule, it is possible to track the issuances of common shares and the increases in the public float. The largest increase in originally issued shares and increase in public float occurred in the period between September 18, 2018 and October 9, 2020 originating from a Section 3(a) (10) of the Securities Act of 1933 program that was filed and approved in Federal Court in early 2018 and the associated convertible fee note. ( Once again a LEGAL MOVE to protect and rid of the issues that OLD ENZC had and note it had to be done LEGALLY)
*
f. Each new issuance under the 3(a)(10) increased the float in the same years and by the same number of shares as the Federal Court approved settlement. This settlement required the original shares be issued with no restrictive legend. The total increase in original issued shares and public float during this two-year period was 1,165,021,256. Total float at December 31, 2020 was 1,670,830,512. Livingston Asset Management held no position in ENZC shares at December 1, 2020( note the wording “no restrictive legend” , which was REQUIRED , if one needs to know, look up the legal definitioin of a SEC 3(a)(10) and it will be explained there. In turn the shares entered the public market , but went from restricted to then public shares and into the Public’s hands now)
*
g. No Dilution has occurred since October 15, 2020, when the total issued reached 2,797,935,953. Float has increased as shareholders who were issued original issuance of ENZC shares met the SEC requirements for removing the restrictive legends and obtained an opinion letter from a SEC approved attorney acceptable to the Transfer Agent representing the Company (Once again the restrictive legends , SEC attorney involved , Transfer agent found acceptable, shares then went into other Public Hands )
*
h. As of December 31, 2021 there were 451,289,565 restricted shares remaining of the 2,797,935,953 originally issued prior to October 15, 2020. Approximately 71 million of these restricted shares are part of a lawsuit filed by the Company. The remaining 380,289,565 have met the SEC requirement for removal of the restrictive legends but have either not elected to or been unable to obtain an opinion letter acceptable to the transfer agent or are held by Officers and directors of the Company.( Explains the remaining Restricted Shares, very simply put)